JP7458788B2 - カプセル化された栄養及び医薬組成物 - Google Patents

カプセル化された栄養及び医薬組成物 Download PDF

Info

Publication number
JP7458788B2
JP7458788B2 JP2019558758A JP2019558758A JP7458788B2 JP 7458788 B2 JP7458788 B2 JP 7458788B2 JP 2019558758 A JP2019558758 A JP 2019558758A JP 2019558758 A JP2019558758 A JP 2019558758A JP 7458788 B2 JP7458788 B2 JP 7458788B2
Authority
JP
Japan
Prior art keywords
oil
composition
emulsion
encapsulated
fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019558758A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020524482A (ja
JP2020524482A5 (cg-RX-API-DMAC10.html
Inventor
ボ・ワン
メク・チュ・ティン・チェン
グレン・エリオット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clover Corp Ltd
Original Assignee
Clover Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017901524A external-priority patent/AU2017901524A0/en
Application filed by Clover Corp Ltd filed Critical Clover Corp Ltd
Publication of JP2020524482A publication Critical patent/JP2020524482A/ja
Publication of JP2020524482A5 publication Critical patent/JP2020524482A5/ja
Priority to JP2023211167A priority Critical patent/JP2024023672A/ja
Application granted granted Critical
Publication of JP7458788B2 publication Critical patent/JP7458788B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
    • A23D9/04—Working-up
    • A23D9/05—Forming free-flowing pieces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2019558758A 2017-04-27 2018-04-27 カプセル化された栄養及び医薬組成物 Active JP7458788B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023211167A JP2024023672A (ja) 2017-04-27 2023-12-14 カプセル化された栄養及び医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017901524 2017-04-27
AU2017901524A AU2017901524A0 (en) 2017-04-27 Encapsulated nutritional and pharmaceutical compositions
PCT/AU2018/050384 WO2018195601A1 (en) 2017-04-27 2018-04-27 Encapsulated nutritional and pharmaceutical compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023211167A Division JP2024023672A (ja) 2017-04-27 2023-12-14 カプセル化された栄養及び医薬組成物

Publications (3)

Publication Number Publication Date
JP2020524482A JP2020524482A (ja) 2020-08-20
JP2020524482A5 JP2020524482A5 (cg-RX-API-DMAC10.html) 2021-05-20
JP7458788B2 true JP7458788B2 (ja) 2024-04-01

Family

ID=63917786

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019558758A Active JP7458788B2 (ja) 2017-04-27 2018-04-27 カプセル化された栄養及び医薬組成物
JP2023211167A Withdrawn JP2024023672A (ja) 2017-04-27 2023-12-14 カプセル化された栄養及び医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023211167A Withdrawn JP2024023672A (ja) 2017-04-27 2023-12-14 カプセル化された栄養及び医薬組成物

Country Status (16)

Country Link
US (2) US20210093578A1 (cg-RX-API-DMAC10.html)
EP (1) EP3614865A4 (cg-RX-API-DMAC10.html)
JP (2) JP7458788B2 (cg-RX-API-DMAC10.html)
KR (2) KR20250099764A (cg-RX-API-DMAC10.html)
CN (1) CN110650636A (cg-RX-API-DMAC10.html)
AU (1) AU2018259160B2 (cg-RX-API-DMAC10.html)
CA (1) CA3062351A1 (cg-RX-API-DMAC10.html)
CL (1) CL2019003072A1 (cg-RX-API-DMAC10.html)
IL (1) IL270157B2 (cg-RX-API-DMAC10.html)
MX (1) MX2019012681A (cg-RX-API-DMAC10.html)
MY (1) MY199653A (cg-RX-API-DMAC10.html)
NZ (1) NZ757794A (cg-RX-API-DMAC10.html)
PE (1) PE20191794A1 (cg-RX-API-DMAC10.html)
PH (1) PH12019502410A1 (cg-RX-API-DMAC10.html)
SG (1) SG11201909228VA (cg-RX-API-DMAC10.html)
WO (1) WO2018195601A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12426615B2 (en) 2019-02-21 2025-09-30 Ingenuity Foods, Inc. Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products
US20210045409A1 (en) * 2019-08-13 2021-02-18 Givaudan S.A. Fat delivery system, fat delivery method and food product containing the fat delivery system
KR102663920B1 (ko) * 2020-11-16 2024-05-07 성균관대학교산학협력단 들기름 분말 제조방법
US12697345B2 (en) * 2021-03-26 2026-08-04 Anabio Technologies Limited Microparticles containing stabilized CBD oil, and methods for the production thereof
KR102687020B1 (ko) * 2021-05-14 2024-07-22 허미진 rTG 오메가-3 제조방법
AU2022304712A1 (en) * 2021-06-28 2023-12-21 Lonza Greenwood Llc Liquid filled capsule with two phase liquid fill
PL4376639T3 (pl) 2021-07-28 2026-06-01 N.V. Nutricia Sposób wytwarzania proszków przez suszenie rozpyłowe i możliwe do otrzymania tak proszki

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006025769A (ja) 2004-07-13 2006-02-02 Kosshi:Kk 健康食品および健康維持方法
JP2009506106A (ja) 2005-08-30 2009-02-12 フイルメニツヒ ソシエテ アノニム カプセル化された活性成分、カプセル化された活性成分の製造方法および使用
JP2011508591A (ja) 2007-12-21 2011-03-17 ビーエーエスエフ ソシエタス・ヨーロピア 脂溶性活性物質を含むマイクロカプセル
US20140030412A1 (en) 2011-02-11 2014-01-30 Clover Corporation Limited Nutritional compositions and uses thereof
US20140154377A1 (en) 2011-04-04 2014-06-05 Dsm Ip Assets B.V. Oil-in-water emulsions comprising a polyunsaturated fatty acid and methods of making the same
JP2014518091A (ja) 2011-07-01 2014-07-28 ペプシコ,インコーポレイテッド コアセルベート複合体、方法および食品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080311255A1 (en) * 2005-02-02 2008-12-18 Dsm Ip Assets B.V. Powder Compositions
NL2003224C2 (en) * 2009-07-17 2011-01-18 Friesland Brands Bv Method for encapsulation of an edible oil, compositions comprising edible oil and the use thereof.
US9585837B2 (en) * 2010-04-09 2017-03-07 Dsm Ip Assets B.V. Thermally stable oil-in-water emulsions containing an oil that contains polyunsaturated fatty acids
WO2013067603A1 (en) * 2011-11-10 2013-05-16 Clover Corporation Limited Encapsulation of food ingredients supplements and pharmaceuticals
EP2792247A1 (en) * 2013-04-19 2014-10-22 Laboratoires Meiners Sarl Encapsulation of an Oil Containing Unsaturated Fatty Acids
RU2666190C2 (ru) * 2013-12-27 2018-09-06 Нестек С.А. Композиция, содержащая сахарат железа и высококонцентрированную микроинкапсулированную дц-пнжк, с уменьшенным посторонним привкусом
GB201509606D0 (en) * 2015-06-03 2015-07-15 Anabio Technologies Ltd Microencapsulates containing stabilised marine-derived oil, and methods for production thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006025769A (ja) 2004-07-13 2006-02-02 Kosshi:Kk 健康食品および健康維持方法
JP2009506106A (ja) 2005-08-30 2009-02-12 フイルメニツヒ ソシエテ アノニム カプセル化された活性成分、カプセル化された活性成分の製造方法および使用
JP2011508591A (ja) 2007-12-21 2011-03-17 ビーエーエスエフ ソシエタス・ヨーロピア 脂溶性活性物質を含むマイクロカプセル
US20140030412A1 (en) 2011-02-11 2014-01-30 Clover Corporation Limited Nutritional compositions and uses thereof
US20140154377A1 (en) 2011-04-04 2014-06-05 Dsm Ip Assets B.V. Oil-in-water emulsions comprising a polyunsaturated fatty acid and methods of making the same
JP2014518091A (ja) 2011-07-01 2014-07-28 ペプシコ,インコーポレイテッド コアセルベート複合体、方法および食品

Also Published As

Publication number Publication date
RU2019137892A3 (cg-RX-API-DMAC10.html) 2021-12-09
IL270157B1 (en) 2023-10-01
JP2020524482A (ja) 2020-08-20
MY199653A (en) 2023-11-14
PE20191794A1 (es) 2019-12-24
AU2018259160B2 (en) 2023-04-27
JP2024023672A (ja) 2024-02-21
CL2019003072A1 (es) 2020-02-28
EP3614865A1 (en) 2020-03-04
IL270157A (cg-RX-API-DMAC10.html) 2019-12-31
AU2018259160A1 (en) 2019-10-24
KR20250099764A (ko) 2025-07-02
PH12019502410A1 (en) 2020-10-19
US20250221939A1 (en) 2025-07-10
CA3062351A1 (en) 2018-11-01
MX2019012681A (es) 2019-12-11
RU2019137892A (ru) 2021-05-27
CN110650636A (zh) 2020-01-03
US20210093578A1 (en) 2021-04-01
NZ757794A (en) 2023-05-26
EP3614865A4 (en) 2021-05-05
IL270157B2 (en) 2024-02-01
BR112019022260A2 (pt) 2020-05-19
KR20190142773A (ko) 2019-12-27
WO2018195601A1 (en) 2018-11-01
SG11201909228VA (en) 2019-11-28

Similar Documents

Publication Publication Date Title
US20250221939A1 (en) Encapsulated nutritional and pharmaceutical compositions
JP2017531429A (ja) 被酸化性成分および水溶性植物抽出物を含む栄養組成物
WO2016193373A1 (en) Microencapsulates containing stabilised lipid, and methods for the production thereof
US20250288529A1 (en) Protein encapsulation of nutritional and pharmaceutical compositions
AU2012280935A1 (en) Encapsulation of food ingredients supplements and pharmaceuticals
EP2672837B1 (en) Nutritional compositions and uses thereof
RU2809106C2 (ru) Инкапсулированные пищевые и фармацевтические композиции
US20240365802A1 (en) Protein encapsulation of nutritional and pharmaceutical compositions
BR112019022260B1 (pt) Composições nutricionais e farmacêuticas encapsuladas
Lee et al. HortResearch, New Zealand

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210407

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220415

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230508

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230814

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231214

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240126

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240319

R150 Certificate of patent or registration of utility model

Ref document number: 7458788

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150